SynthesisHuman genomics2026
The genetic insights of sporadic male infertility: a systematic review of WES and WGS studies (2014-2024).
Synthesis in Human genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Male infertility is a complex and heterogeneous disorder. It has a significant genetic component, although some cases remain idiopathic. Next-generation sequencing, particularly whole-exome (WES) and whole-genome sequencing (WGS) has become a powerful tool for uncovering new genetic causes. This systematic review aimed to identify and synthesize genes linked to male infertility reported in WES or WGS studies. The review was registered on PROSPERO (CRD42024597301). A bibliographic search was conducted on PubMed, Scopus, and Web of Science (2014-2024). We included human studies that used WES or WGS to investigate the genetics of male infertility. Two reviewers independently performed screening, data extraction, and risk-of-bias assessment with JBI checklists. Out of 8018 identified records, 23 studies met the inclusion criteria. In total, 169 unique genes were reported; after removing duplicates, 143 genes remained. The most frequently implicated phenotypes were multiple morphological abnormalities of the flagella (MMAF) and non-obstructive azoospermia (NOA). Genes were stratified by recurrence across independent cohorts and by functional validation status. Of the 143 genes, five were replicated with functional validation, 22 demonstrated either replication or functional validation, and 116 were reported in single studies with only in silico support. In studies applying the criteria of American College of Medical Genetics and Genomics (ACMG), the diagnostic yield was 48% for MMAF and 12-23% for NOA, with an average variant-of-uncertain-significance (VUS) burden of 47%. ACMG classification was inconsistently applied across studies. MMAF-associated genes were predominantly autosomal recessive (95%), whereas NOA-associated genes exhibited greater diversity: 60% autosomal recessive, 25% X-linked, and 15% autosomal dominant. Only 34% of genes had undergone functional validation. In summary, among WES and WGS studies of predominantly sporadic cohorts, most identified genes were reported in single studies without functional validation, and standardized variant classification was implemented in only a minority of studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.